The Impact of a Helplessness and Recovery of an Empowerment Intervention on People Diagnosed With Schizophrenia: Findings From a Randomized Controlled Trial
Primary Purpose
Psychotic Disorders
Status
Completed
Phase
Phase 2
Locations
Study Type
Interventional
Intervention
Empowerment
Sponsored by
About this trial
This is an interventional supportive care trial for Psychotic Disorders
Eligibility Criteria
Inclusion Criteria:
- Adult aged 16 years or more
- Able to read and write in an Arabic
- Able to consent
- Diagnosed with schizophrenia
- Volunteers
Exclusion Criteria:
- Learning disability
- Not able to read or write
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Intervention
Treatment as usual
Arm Description
Intervention group received 6 weeks of empowerment program
Medications
Outcomes
Primary Outcome Measures
Modified Learned Helplessness
Outcome was measured at baseline (November) and immediately post intervention (February) and at three months follow up (May)
Secondary Outcome Measures
Psychiatric symptoms
Outcome was measured at baseline (November) and immediately post intervention (February) and at three months follow up (May)
recovery assessment scale
Outcome was measured at baseline (November) and immediately post intervention (February) and at three months follow up (May)
Empowerment level
Outcome was measured at baseline (November) and immediately post intervention (February) and at three months follow up (May)
Quality of life
Outcome was measured at baseline (November) and immediately post intervention (February) and at three months follow up (May)
Full Information
NCT ID
NCT02968667
First Posted
November 14, 2016
Last Updated
November 17, 2016
Sponsor
Fakeeh College for Medical Sciences
1. Study Identification
Unique Protocol Identification Number
NCT02968667
Brief Title
The Impact of a Helplessness and Recovery of an Empowerment Intervention on People Diagnosed With Schizophrenia: Findings From a Randomized Controlled Trial
Official Title
The Effectiveness of Hopelessness and Helplessness on Recovery Rate Among People Diagnosed With Schizophrenia
Study Type
Interventional
2. Study Status
Record Verification Date
November 2016
Overall Recruitment Status
Completed
Study Start Date
November 2015 (undefined)
Primary Completion Date
May 2016 (Actual)
Study Completion Date
May 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Fakeeh College for Medical Sciences
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
A randomized controlled trial was conducted from November 2015 and May 2016 with 112 participants of people diagnosed with schizophrenia. Participants aged 18 years or older with Diagnostic Statistical Manual (DSM-V) schizophrenia or schizoaffective disorder from outpatient mental health clinics in Jordan, were randomly assigned participants either to receive 6 weeks of a booklet form of intervention with face to face discussion, and treatment as usual (TAU) (intervention, n = 56), or TAU (control, n = 56). Participants were assessed at baseline, immediately post-intervention (post-treatment1) and at three months follow-up. The primary outcome measure was change in helplessness score . Secondary outcomes for PDwS were psychiatric symptoms, recovery rate and quality of life.
Detailed Description
A randomized controlled trial was conducted from November 2015 and May 2016 with 112 participants of people diagnosed with schizophrenia. Participants aged 18 years or older with DSM-V schizophrenia or schizoaffective disorder from outpatient mental health clinics in Jordan, were randomly assigned participants either to receive 6 weeks of a booklet form of intervention with face to face discussion, and treatment as usual [TAU] (intervention, n = 56), or TAU (control, n = 56). Participants were assessed at baseline, immediately post-intervention (post-treatment1) and at three months follow-up. The primary outcome measure was change in helplessness score . Secondary outcomes for PDwS were psychiatric symptoms, recovery rate and quality of life.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Psychotic Disorders
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
102 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Intervention
Arm Type
Experimental
Arm Description
Intervention group received 6 weeks of empowerment program
Arm Title
Treatment as usual
Arm Type
No Intervention
Arm Description
Medications
Intervention Type
Behavioral
Intervention Name(s)
Empowerment
Intervention Description
6 weeks of empowerment program and supported face to face discussion
Primary Outcome Measure Information:
Title
Modified Learned Helplessness
Description
Outcome was measured at baseline (November) and immediately post intervention (February) and at three months follow up (May)
Time Frame
Up to 6 months
Secondary Outcome Measure Information:
Title
Psychiatric symptoms
Description
Outcome was measured at baseline (November) and immediately post intervention (February) and at three months follow up (May)
Time Frame
Up to 6 months
Title
recovery assessment scale
Description
Outcome was measured at baseline (November) and immediately post intervention (February) and at three months follow up (May)
Time Frame
Up to 6 months
Title
Empowerment level
Description
Outcome was measured at baseline (November) and immediately post intervention (February) and at three months follow up (May)
Time Frame
Up to 6 months
Title
Quality of life
Description
Outcome was measured at baseline (November) and immediately post intervention (February) and at three months follow up (May)
Time Frame
Up to 6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
16 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Adult aged 16 years or more
Able to read and write in an Arabic
Able to consent
Diagnosed with schizophrenia
Volunteers
Exclusion Criteria:
Learning disability
Not able to read or write
12. IPD Sharing Statement
Learn more about this trial
The Impact of a Helplessness and Recovery of an Empowerment Intervention on People Diagnosed With Schizophrenia: Findings From a Randomized Controlled Trial
We'll reach out to this number within 24 hrs